CASPR2 Antibody, Clone FF19: PerCP

CASPR2, a member of the neurexin superfamily, is a critical axonal membrane protein that regulates the organization of myelinated nerve fibers. Unlike CASPR, which localizes to the paranodal junction, CASPR2 is enriched at the juxtaparanodal region of the axon, where it functions as a membrane scaffold essential for clustering voltage-gated Kv1 potassium channels. This spatial arrangement is vital for maintaining axonal excitability and signal fidelity. CASPR2 interacts with contactin-2 and cytoskeletal adaptor protein 4.1B to stabilize the juxtaparanodal domain, contributing to the compartmentalization of axonal regions around the nodes of Ranvier. Disruption of CASPR2 function impairs ion channel localization and axonal conduction, leading to altered neuronal signaling. Emerging evidence links CASPR2 dysfunction to a spectrum of neurodevelopmental and neurodegenerative disorders, including epilepsy, autism spectrum disorders, and autoimmune encephalitis. In neurodegenerative disease contexts, CASPR2-associated disorganization of axonal domains may contribute to demyelination, synaptic dysfunction, and progressive neuronal loss. Given its role in maintaining axonal architecture and electrical signaling, CASPR2 is increasingly recognized as a potential biomarker and therapeutic target in diseases affecting white matter integrity and neural connectivity.

WB (1:1000), IHC (1:100), ICC/IF (1:100) ; optimal dilutions for assays should be determined by the user.; optimal dilutions for assays should be determined by the user.

1. Wu, L., et al. (2023) . CASPR2 antibody associated neurological syndromes in children. Scientific Reports, 13, 2073. DOI: 10.1038/s41598-023-28268-x 2. Poliak, S. & Peles, E. (2003) . The local differentiation of myelinated axons at nodes of Ranvier. Nature Reviews Neuroscience, 4, 968-980. DOI: 10.1038/nrn1253 3. Horresh, I., Bar, V., Kissil, J.L., & Peles, E. (2010) . Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal linker protein 4.1B. Journal of Neuroscience, 30 (7), 2480-2489. DOI: 10.1523/JNEUROSCI.5225-09.2010 4. Gollan, L., Salomon, D., Salzer, J.L., & Peles, E. (2003) . Caspr regulates the processing of contactin and inhibits its binding to neurofascin. Journal of Biological Chemistry, 278 (25), 23749-23758. DOI: 10.1074/jbc.M303484200 5. Joubert, B. et al. (2016) . Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol. 73 (9), 1115–1124. DOI: 10.1001/jamaneurol.2016.1585